Clopidogrel for Acute Ischaemia of Recent Onset

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 188 participants.

Also called NCT02776540

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 188 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02776540
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02776540. Randomized; triple masking; primary purpose treatment. Start 2016-06-01 (actual); primary completion 2019-02-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clopidogrel for Acute Ischaemia of Recent Onset
Acronym
CAIRO
Condition
Ischemic Cerebrovascular Accident
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Aspirin
Lead sponsor
Ain Shams University (class: other)

Record details

Record id
cardio:ct-nct02776540
Content hash
3fd76ee65348e6e828265f5255d20aa54032d407e0480fe90c042225c77bd096